DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Panacea Biotec Limited — Updates

NSE 1 hr ago·7 Oct 2026, 10:27 am

Panacea Biotec

Panacea Biotec Limited has informed the stock exchanges that a specific number of its shares have been dematerialized during the month of September 2026. This move involves converting physical share certificates into electronic form held in a Demat account.

For investors, this is a routine administrative update that signifies a change in shareholding pattern. It does not reflect any change in the company's financial health or market performance. The transaction is part of the standard process for shareholders to hold their equity in a digital format.

Investors should monitor the company's upcoming quarterly results and any announcements regarding new product launches. These factors will be more relevant to the stock's price action than the dematerialization of shares.